ADAM17 and metabolic disease: Inactivation of ADAM17 suppressed high-fat diet (HFD) induced obesity, insulin resistance, hepatosteatosis, and adipose tissue remodeling in mice, with increased energy expenditure, suggesting an essential role for ADAM17 in the development of obesity-induced metabolic disorders [76].